Ardisiacrispin B is a natural chemical compound derived from the plant Ardisia crispa, belonging to the triterpenoid saponin class. It has been identified to possess a range of biological activities, including anti-inflammatory and anti-oxidant properties, which contribute to its potential as a valuable compound for pharmaceutical development. Furthermore, its cytotoxic effects on cancer cells suggest a promising application in cancer therapy, marking ardisiacrispin B as a significant discovery for the advancement of novel drugs to address various medical conditions.
112766-96-8
Post Buying Request-
-
Basic information
- Product Name: ardisiacrispin B
- Synonyms: ardisiacrispin B
- CAS NO:112766-96-8
- Molecular Formula: C53H86 O22
- Molecular Weight: 1075.24
- EINECS: N/A
- Product Categories: N/A
-
Chemical Properties
- Melting Point: N/A
- Boiling Point: °Cat760mmHg
- Flash Point: °C
- Appearance: /
- Density: 1.46g/cm3
- Refractive Index: 1.63
- Storage Temp.: N/A
- Solubility: N/A
- CAS DataBase Reference: ardisiacrispin B(CAS DataBase Reference)
- NIST Chemistry Reference: ardisiacrispin B(112766-96-8)
- EPA Substance Registry System: ardisiacrispin B(112766-96-8)
-
Safety Data
- Hazard Codes: N/A
- Statements: N/A
- Safety Statements: N/A
- WGK Germany:
- RTECS:
- HazardClass: N/A
- PackingGroup: N/A
- Hazardous Substances Data: 112766-96-8(Hazardous Substances Data)
112766-96-8 Suppliers
Recommended suppliers
112766-96-8 Usage
Uses
Used in Pharmaceutical Development:Ardisiacrispin B is used as a lead compound for the development of new pharmaceuticals due to its anti-inflammatory and anti-oxidant properties. These characteristics make it a candidate for treating conditions that involve inflammation and oxidative stress.
Used in Cancer Therapy:
In the field of oncology, ardisiacrispin B is used as a cytotoxic agent against cancer cells. Its potential to target and eliminate cancerous cells positions it as a promising component in the development of cancer treatment strategies.
Used in Drug Delivery Systems:
To enhance the therapeutic efficacy and bioavailability of ardisiacrispin B, it can be incorporated into drug delivery systems. These systems may employ various carriers, such as organic and metallic nanoparticles, to improve the compound's delivery to target sites, ensuring optimal pharmacological outcomes.
Check Digit Verification of cas no
The CAS Registry Mumber 112766-96-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,2,7,6 and 6 respectively; the second part has 2 digits, 9 and 6 respectively.Calculate Digit Verification of CAS Registry Number 112766-96:
(8*1)+(7*1)+(6*2)+(5*7)+(4*6)+(3*6)+(2*9)+(1*6)=128
128 % 10 = 8
So 112766-96-8 is a valid CAS Registry Number.
InChI:InChI=1/C53H86O22/c1-23-32(58)36(62)39(65)43(69-23)75-42-38(64)34(60)25(19-55)71-46(42)72-26-20-67-45(41(35(26)61)74-44-40(66)37(63)33(59)24(18-54)70-44)73-31-10-11-49(5)27(47(31,2)3)8-12-50(6)28(49)9-13-53-29-16-48(4,21-56)14-15-52(29,22-68-53)30(57)17-51(50,53)7/h21,23-46,54-55,57-66H,8-20,22H2,1-7H3/t23-,24?,25+,26-,27-,28+,29+,30+,31-,32-,33+,34+,35-,36+,37-,38-,39+,40+,41+,42+,43-,44-,45-,46-,48-,49-,50+,51-,52?,53?/m0/s1
112766-96-8Upstream product
112766-96-8Downstream Products
112766-96-8Related news
A naturally occuring triterpene saponin ardisiacrispin B (cas 112766-96-8) displayed cytotoxic effects in multi-factorial drug resistant cancer cells via ferroptotic and apoptotic cell death07/23/2019
IntroductionMultidrug resistance of cancer cells constitutes a serious problem in chemotherapy and a challenging issue in the discovery of new cytotoxic drugs. Many saponins are known to display anti-cancer effects. In this study, the cytotoxicity and the modes of action of a naturally occuring ...detailed
Post a RFQ
1
What can I do for you?
Get Best Price
Get Best Price for 112766-96-8
ardisiacrispin B
